6 days ago 8

ALSANA APPOINTS KEESHA AMEZCUA, LMFT, CEDS-C AS NEW CHIEF CLINICAL OFFICER

An internationally recognized industry leader brings 20 of experience to Alsana's eating recovery community.

, /PRNewswire/ -- Alsana, an eating recovery community with in-person and virtual treatment programs, has appointed Keesha Amezcua, MA, LMFT, CEDS-C as its new chief clinical officer. With 20 years of eating disorder treatment experience, Amezcua brings a wealth of clinical expertise to the organization. In addition to her clinical work, she has contributed to books, articles and media on eating disorder recovery and is a frequent speaker at national conferences. She is speaking at this year's International Association of Eating Disorder Professionals' National Conference on ADHD and eating disorders entitled "ADHD, It Takes a Village: A Panel Discussion."

Amezcua will lead all aspects of Alsana's clinical care, client experience, treatment outcomes, Adaptive Care Model^®, program development, and training for clinical teams.

"Keesha's expertise and proven ability to lead treatment teams to deliver excellent care highlights our company's commitment to clinical outcomes and client experience," said Jordan Watson, Alsana's CEO. "The future of the eating disorder treatment field will be determined by those who are willing to invest in clinical leadership and work to attract, develop and train treatment teams. I am confident that under Keesha's leadership, Alsana will deliver industry-leading care, create a magnetic culture for professionals seeking to work in eating disorder treatment, and shape the future of our industry for the better."

Amezcua brings extensive clinical leadership experience over all levels of care for both adolescents and adults previously serving as Vice President of Clinical Programming for Monte Nido & Affiliates. Amezcua, in her previous role, oversaw care delivery, clinical outcomes and staff training nationally during periods of high growth. In addition, she has international program development experience contributing to Wandi Nerida, Australia's first residential eating disorder treatment center.

"I am honored to step into the role of chief clinical officer at Alsana. As we navigate the ever-changing clinical landscape, my priority is to uphold and enhance the highest standards of care for our clients while empowering, training and supporting our clinical teams," said Keesha Amezcua, Alsana's new chief clinical officer. "I have seen Alsana's commitment to evolving services that meet the needs of the moment. I am excited to contribute to this ongoing effort— driving innovation, improving client outcomes and investing in our clinical team members."

Amezcua is a Certified Eating Disorder Specialist Consultant (CEDS-C), a Licensed Marriage and Family Therapist in California, Texas and Oregon, and a Certified Daring Way Facilitator (CDWF). She has specialized training in Eye Movement Desensitization and Reprocessing (EMDR) and Cognitive Processing Therapy (CPT). Prior to entering the mental health field, she graduated with honors from Texas A&M University with a bachelor's degree in journalism and worked in magazine editorial, television production, and marketing and advertising.

About Alsana^®Alsana is an eating recovery community with Virtual Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs across the United States for adults and adolescents, in addition to in-person Residential and PHP/IOP programs in Alabama and California for adults. Its eating disorder treatment programs are compassion-focused, evidence-based, and designed in alignment with Alsana's Adaptive Care Model^®. This whole-person approach addresses healing in all areas of clients' lives by integrating medical, nutritional, and therapeutic care with movement and relational therapies. Alsana serves adult clients of all genders and sexual identities struggling with a broad spectrum of eating, feeding, and co-occurring mental health conditions. Alsana's programs accommodate the unique needs of vegan clients and clients struggling with ED-DMT1, also known as "diabulimia." Learn more at www.alsana.com.